Carbohydrates are often displayed in large quantities on the surface of normal and tumor cells in the form of glycoconjugates, such as glycolipids and glycoproteins. Among them, special glycans expressed by cancer cells are known as tumor-associated antigens. It is a useful molecular target for the development of new cancers, tumor therapies, and diagnostics. Among the tumor-associated antigens, the structure of globo-H antigen has a b-GalNAc-(1→3)-a-Gal-(1→4)-Gal oligosaccharide part. It belongs to a hexasaccharide sphingolipid and is present in many tumors in the human body, especially breast, prostate, and lung cancers. Therefore, globo-H has become an important target for the Development of Tumor-Associated Carbohydrate Vaccines.
Fig.1 Structure of tumor-associated globo-H antigen. (Mandal, et al., 2015)
Globo-H antigen is expressed in many types of tumor cells and plays a key role in the development of anti-tumor vaccines. At CD BioGlyco, we provide our clients the tumor-associated globo-H antigen production services under the general direction of vaccine development.
Fig.2 Composition of the vaccine. (CD BioGlyco)
Because globo-H is expressed on many tumors in the human body, we also offer the development of anti-tumor vaccines using globo-H as an antigen in combination with substances such as preservatives, stabilizers, surfactants, diluents, and adjuvants.
Fig.3 Antigen synthesis and vaccine development services. (CD BioGlyco)
CD BioGlyco has extensive experience in the Production of Tumor-Associated Globo Protein Antigens and can provide clients with a wide range of antigen types as well as vaccine development services. Currently, we have mastered the production of the tumor-associated globo-H antigen. Please feel free to contact us if you are interested in our services and have any questions.
References